Nutex Health (NASDAQ:NUTX) Trading Up 1.1% – Should You Buy?

Nutex Health Inc. (NASDAQ:NUTX)’s share price was up 1.1% during mid-day trading on Thursday . The stock traded as high as $151.00 and last traded at $149.10. 77,009 shares were traded during trading, a decline of 37% from the average daily volume of 122,047 shares. The stock had previously closed at $147.54.

Analyst Upgrades and Downgrades

NUTX has been the topic of a number of research reports. Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Wall Street Zen upgraded shares of Nutex Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Finally, Lake Street Capital began coverage on shares of Nutex Health in a research report on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 target price for the company. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $220.00.

Nutex Health Trading Up 1.1%

The company has a fifty day simple moving average of $128.09 and a two-hundred day simple moving average of $130.09. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.12. The company has a market capitalization of $1.03 billion, a P/E ratio of 11.52 and a beta of 0.26.

Nutex Health (NASDAQ:NUTX) last announced its quarterly earnings results on Thursday, April 30th. The company reported $6.52 earnings per share for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53. The company had revenue of $216.49 million during the quarter, compared to analysts’ expectations of $227.80 million. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%.

Institutional Investors Weigh In On Nutex Health

A number of large investors have recently added to or reduced their stakes in NUTX. Deutsche Bank AG raised its position in shares of Nutex Health by 3.9% in the fourth quarter. Deutsche Bank AG now owns 2,633 shares of the company’s stock valued at $433,000 after purchasing an additional 98 shares during the period. Russell Investments Group Ltd. boosted its holdings in shares of Nutex Health by 1.4% during the 4th quarter. Russell Investments Group Ltd. now owns 8,706 shares of the company’s stock worth $1,433,000 after buying an additional 116 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al boosted its holdings in shares of Nutex Health by 3.7% during the 4th quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 5,600 shares of the company’s stock worth $922,000 after buying an additional 200 shares during the period. Islay Capital Management LLC acquired a new position in Nutex Health in the 4th quarter valued at $34,000. Finally, First Trust Advisors LP grew its stake in Nutex Health by 2.4% in the 4th quarter. First Trust Advisors LP now owns 11,461 shares of the company’s stock valued at $1,887,000 after buying an additional 272 shares during the last quarter. Institutional investors own 5.32% of the company’s stock.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.